CytoSorbents Commemorates World Sepsis Day and Sepsis Awareness Month with Key Sepsis-Related Events, Sponsorships and StudiesPRNewsWire • 09/13/21
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ Antithrombotic Removal System During Urgent Cardiothoracic SurgeryPRNewsWire • 09/10/21
CytoSorbents Announces Webinar Discussing Topline Results from the U.S. CTC Registry using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)PRNewsWire • 09/08/21
CytoSorbents' Product Associated With High Survival In Critically Ill COVID-19 PatientsBenzinga • 09/01/21
Topline Results from CytoSorbents' U.S. CTC Multicenter Registry Demonstrate High Survival using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)PRNewsWire • 09/01/21
CytoSorbents and Aferetica Announce the Commercial Launch in Italy of the PerSorb™ Adsorber and PerLife™ Organ Perfusion System, respectively, at the European Society of Organ Transplantation CongressPRNewsWire • 08/30/21
CytoSorbents' Antithrombotic Removal System Scores Second FDA Breakthrough Device TagBenzinga • 08/12/21
Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR™ Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic SurgeryPRNewsWire • 08/12/21
CytoSorbents Corporation (CTSO) CEO Phillip Chan on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
CytoSorbents Completes its Mission 100,000 International Fundraising Campaign to Fight the Spread of COVID-19 for Global Humanitarian Organization, CAREPRNewsWire • 07/30/21
CytoSorbents Shares Are Trading Higher On Launch Of Trial On Ticagrelor Removal During Cardiothoracic SurgeryBenzinga • 07/06/21
CytoSorbents Receives Full FDA Approval of Investigational Device Exemption (IDE) for U.S. STAR-T Trial on Ticagrelor Removal During Cardiothoracic SurgeryPRNewsWire • 07/06/21
CytoSorbents Appoints Terri Anne Powers, IRC as Vice President of Investor Relations and Corporate CommunicationsPRNewsWire • 06/01/21
CytoSorbents to Present at the UBS Global Healthcare Virtual Conference and Oppenheimer MedTech, Tools and Diagnostic SummitPRNewsWire • 05/19/21
CytoSorbents Awarded $1.5 Million Sequential Phase II SBIR Contract to Advance the Treatment of Severe Hyperkalemia in Traumatic InjuryPRNewsWire • 05/11/21